Developing practice recommendations for endovascular revascularization for acute ischemic stroke

Neurology

Volumn 79, Issue 13 SUPPL. 1, 2012, Pages

  Lazzaro, Marc A ^a   Novakovic, Roberta L ^b   Alexandrov, Andrei V ^c   Darkhabani, Ziad ^a   Edgell, Randall C ^d   English, Joey ^e   Frei, Donald ^f   Jamieson, Dara G ^g   Janardhan, Vallabh ^h   Janjua, Nazli ⁱ   Janjua, Rashid M ^j   Katzan, Irene ^k   Khatri, Pooja ^l   Kirmani, Jawad F ^m   Liebeskind, David S ⁿ   Linfante, Italo ^o   Nguyen, Thanh N ^p   Saver, Jeffrey L ⁿ   Shutter, Lori ^l   Xavier, Andrew ^q   Yavagal, Dileep ^r   Zaidat, Osama O ^a   more..

^a FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d SAINT LOUIS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f Radiology Imaging Associates   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h Texas Stroke Institute   (United States)

ⁱ Asia Pacific Comprehensive Stroke Institute   (United States)

^j WAKE FOREST BAPTIST HEALTH   (United States)

^k LERNER RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF CINCINNATI   (United States)

^m NEW JERSEY NEUROSCIENCE INSTITUTE   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o Baptist Medical Center   (United States)

^p BOSTON UNIVERSITY   (United States)

^q WAYNE STATE UNIVERSITY   (United States)

^r UNIVERSITY OF MIAMI   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; CLOPIDOGREL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PROUROKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; BLOOD PRESSURE MONITORING; BRAIN ISCHEMIA; CATHETERIZATION; CEREBRAL REVASCULARIZATION; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; ENDOVASCULAR SURGERY; GLYCEMIC CONTROL; HEALTH CARE PLANNING; HUMAN; MEDICAL SOCIETY; NEUROMONITORING; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ARTICLE; ENDOVASCULAR REVASCULARIZATION; MEDICAL LITERATURE; MIDDLE CEREBRAL ARTERY OCCLUSION; PATHOPHYSIOLOGY; PATIENT SAFETY; REVASCULARIZATION; THERAPY EFFECT;

EID: 84867551015     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31826959fc     Document Type: Article

References (68)

1. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups. Stroke 2007;38:1655-1711.
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
3. Zaidat OO, Suarez JI, Sunshine JL, et al. Thrombolytic therapy of acute ischemic stroke: correlation of angiographic recanalization with clinical outcome. AJNR Am J Neuroradiol 2005;26:880-884.
4. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007;38:967-973.
5. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke: PROACT Investigators: Prolyse in Acute Cerebral Thromboembolism. Stroke 1998;29:4-11.
6. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial: Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
7. Alberts MJ, Latchaw RE, Selman WR, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36:1597-1616.
8. Leifer D, Bravata DM, Connors JJ 3rd, et al. Metrics for measuring quality of care in comprehensive stroke centers: detailed follow-up to Brain Attack Coalition comprehensive stroke center recommendations: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:849-877.
9. Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009;119:2235-2249.
10. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:1432-1438.
11. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 2009;40:2761-2768.
12. Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan. Stroke 2007;38:2633-2639.
13. Lee M, Hong KS, Saver JL. Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke 2010;41:932-937.
14. Inoue T, Kimura K, Minematsu K, Yamaguchi T. A casecontrol analysis of intra-arterial urokinase thrombolysis in acute cardioembolic stroke. Cerebrovasc Dis 2005;19:225-228.
15. Nogueira RG, Liebeskind DS, Sung G, Duckwiler G, Smith WS. Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke 2009;40:3777-3783.
16. Saver JL, Liebeskind DS, Nogueira RG, Jahan R. Need to clarify Thrombolysis In Myocardial Ischemia (TIMI) scale scoring method in the Penumbra Pivotal Stroke Trial. Stroke 2010;41:e115-e116.
17. Intra-arterial Versus Systemic Thrombolysis for Acute Ischemic Stroke: SYNTHESIS EXP. Available at: strokecenter.org. Accessed November 26, 2011.
18. MRCLEAN: a multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke in the Netherlands. 2011. Available at: www.trialregister.nl/trialreg/admin/rctview.asp?TC=1804. Accessed November 26, 2011.
19. Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy: MR RESCUE. Available at: clinicaltrials. gov/ct2/show/NCT00389467. Accessed November 26, 2011.
20. Assess the Penumbra System in the Treatment of Acute Stroke (THERAPY). Available at: clinicaltrials.gov/ct2/show/NCT01429350. Accessed November 26, 2011.
21. The Interventional Management of Stroke (IMS) trials. Available at: http://www.strokecenter.org/trials/trialDetail.aspx?tid=747. Accessed August 26, 2011.
22. Zaidat OO, Wolfe T, Hussain SI, et al. Interventional acute ischemic stroke therapy with intracranial self-expanding stent. Stroke 2008;39:2392-2395.
23. Roth C, Papanagiotou P, Behnke S, et al. Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 2010;41:2559-2567.
24. Castano C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke 2010;41:1836-1840.
25. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
26. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial: Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019-2026.
27. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009;40:2945-2948.
28. Eckert B, Kucinski T, Pfeiffer G, Groden C, Zeumer H. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002;14:42-50.
29. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008;39:1205-1212.
30. Schulte-Altedorneburg G, Hamann GF, Mull M, et al. Outcome of acute vertebrobasilar occlusions treated with intra-arterial fibrinolysis in 180 patients. AJNR Am J Neuroradiol 2006;27:2042-2047.
31. Arnold M, Nedeltchev K, Schroth G, et al. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75:857-862.
32. Schonewille WJ, Wijman CA, Michel P, et al. Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study. Lancet Neurol 2009;8:724-730.
33. Mishra NK, Albers GW, Davis SM, et al. Mismatch-based delayed thrombolysis: a meta-analysis. Stroke 2010;41:e25-e33.
34. Jovin TG, Liebeskind DS, Gupta R, et al. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well: retrospective multicenter analysis of 237 consecutive patients. Stroke 2011;42:2206-2211.
35. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS) JAMA 1995;274:1017-1125.
36. Pexman JH, Barber PA, Hill MD, et al. Use of the Alberta Stroke Program Early CT Score (ASPECTS) for assessing CT scans in patients with acute stroke. AJNR Am J Neuroradiol 2001;22:1534-1542.
37. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007;38:948-954.
38. Mathews MS, Sharma J, Snyder KV, et al. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. Neurosurgery 2009;65:860-865, 2009.
39. Gupta R, Tayal AH, Levy EI, et al. Intra-arterial thrombolysis or stent placement during endovascular treatment for acute ischemic stroke leads to the highest recanalization rate: results of a multicenter retrospective study. Neurosurgery 2011;68:1618-1623.
40. The Interventional Management of Stroke (IMS) II study. Stroke 2007;38:2127-2135.
41. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenousendovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009;8:802-809.
42. Rubiera M, Ribo M, Pagola J, et al. Bridging intravenousintraarterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a casecontrol study. Stroke 2011;42:993-997.
43. Costalat V, Machi P, Lobotesis K, et al. Rescue, combined, and stand-alone thrombectomy in the management of large vessel occlusion stroke using the solitaire device: a prospective 50-patient single-center study: timing, safety, and efficacy. Stroke 2011;42:1929-1935.
44. Eckert B, Koch C, Thomalla G, et al. Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 2005;36:1160-1165.
45. Pfefferkorn T, Mayer TE, Opherk C, et al. Staged escalation therapy in acute basilar artery occlusion: intravenous thrombolysis and on-demand consecutive endovascular mechanical thrombectomy: preliminary experience in 16 patients. Stroke 2008;39:1496-1500.
46. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology 2009;73:1066-1072.
47. Nogueira RG, Smith WS, Sung G, et al. Effect of time to reperfusion on clinical outcome of anterior circulation strokes treated with thrombectomy: pooled analysis of the MERCI and Multi MERCI trials. Stroke Epub 2011 Sept 15.
48. NINDS: Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. National Institute of Neurological Disorders and Stroke, 2011. Available at: http://www.ninds.nih.gov/news-and-events/ proceedings/stroke-proceedings/execsum.htm. Accessed September 15, 2011.
49. Mattle HP, Arnold M, Georgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke 2008;39:379-383.
50. Wolfe T, Suarez JI, Tarr RW, et al. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke. J Stroke Cerebrovasc Dis 2008;17:121-128.
51. Suarez JI, Sunshine JL, Tarr R, et al. Predictors of clinical improvement, angiographic recanalization, and intracranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 1999;30:2094-2100.
52. Flaherty ML, Woo D, Kissela B, et al. Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005;64:386-388.
53. Miley JT, Memon MZ, Hussein HM, et al. A multicenter analysis of "time to microcatheter" for endovascular therapy in acute ischemic stroke. J Neuroimaging 2011;21:159-64.
54. Ducrocq X, Bracard S, Taillandier L, et al. Comparison of intravenous and intra-arterial urokinase thrombolysis for acute ischaemic stroke. J Neuroradiol 2005;32:26-32.
55. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-911.
56. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intraarterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598-2605.
57. Lazzaro MA LV, Mohammad Y, Chen M, Lopes DK, Prabhakaran S. Weekend effect is not observed in time to angiography for transferred acute ischemic stroke patients. Cerebrovasc Diseases 2010;29(suppl 2):329.
58. Lindsberg PJ, Happola O, Kallela M, Valanne L, Kuisma M, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 2006;67:334-336.
59. Prabhakaran S, Ward E, John S, et al. Transfer delay is a major factor limiting the use of intra-arterial treatment in acute ischemic stroke. Stroke 2011;42:1626-1630.
60. Crocco TJ, Grotta JC, Jauch EC, et al. EMS management of acute stroke-prehospital triage (resource document to NAEMSP position statement). Prehosp Emerg Care 2007;11:313-317.
61. Pfefferkorn T, Holtmannspotter M, Schmidt C, et al. Drip, ship, and retrieve: cooperative recanalization therapy in acute basilar artery occlusion. Stroke 2010;41:722-726.
62. Abou-Chebl A, Lin R, Hussain MS, et al. Conscious sedation versus general anesthesia during endovascular therapy for acute anterior circulation stroke: preliminary results from a retrospective, multicenter study. Stroke 2010;41:1175-1179.
63. Gupta R. Local is better than general anesthesia during endovascular acute stroke interventions. Stroke 2010;41:2718-2719.
64. Nahab F, Walker GA, Dion JE, Smith WS. Safety of periprocedural heparin in acute ischemic stroke endovascular therapy: the Multi MERCI trial. J Stroke Cerebrovasc Dis Epub 2011 June 1.
65. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-Induced Nephropathy Trial (ACT). Circulation 2011;124:1250-1259.
66. Kase CS, Furlan AJ, Wechsler LR, et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 2001;57:1603-1610.
67. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with STelevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol 2004;44:E1-E211.
68. Fonarow GC, Smith EE, Saver JL, et al. Improving doortoneedle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's target: stroke initiative. Stroke 2011;42:2983-2989.